Business Description
Arctic Bioscience AS
ISIN : NO0010859580
Compare
Compare
Traded in other countries / regions
ABS.Norway9TD.Germany IPO Date
2021-02-24Description
Arctic Bioscience AS is a Norwegian biotechnology company. The company is focused on developing products and solutions based on bioactive marine compounds. The product portfolio includes nutraceuticals and pharmaceuticals. It is currently developing a novel, cost-efficient oral treatment (HRO350) for mild-to-moderate psoriasis. Its nutraceutical products are sold globally to both B2C and B2B under the Romega brand.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 14.06 | |||||
| Equity-to-Asset | 0.86 | |||||
| Debt-to-Equity | 0.02 | |||||
| Debt-to-EBITDA | -0.14 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | 3.72 | |||||
| Beneish M-Score | -2.25 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 16.3 | |||||
| 3-Year EBITDA Growth Rate | -21.4 | |||||
| 3-Year EPS without NRI Growth Rate | -24.4 | |||||
| 3-Year FCF Growth Rate | -32.3 | |||||
| 3-Year Book Growth Rate | 57.1 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 35.81 | |||||
| 9-Day RSI | 43.47 | |||||
| 14-Day RSI | 46.99 | |||||
| 6-1 Month Momentum % | 9.38 | |||||
| 12-1 Month Momentum % | -9.26 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.36 | |||||
| Quick Ratio | 2.53 | |||||
| Cash Ratio | 1.98 | |||||
| Days Inventory | 525.85 | |||||
| Days Sales Outstanding | 143.06 | |||||
| Days Payable | 256.68 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -1.4 | |||||
| Shareholder Yield % | -7.95 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 28.96 | |||||
| Operating Margin % | -143.96 | |||||
| Net Margin % | -134.86 | |||||
| FCF Margin % | -253.69 | |||||
| ROE % | -16.47 | |||||
| ROA % | -14.38 | |||||
| ROIC % | -26.27 | |||||
| ROC (Joel Greenblatt) % | -116.63 | |||||
| ROCE % | -15.99 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 7.84 | |||||
| PB Ratio | 1.02 | |||||
| Price-to-Tangible-Book | 2.12 | |||||
| EV-to-EBIT | -3.97 | |||||
| EV-to-EBITDA | -4.52 | |||||
| EV-to-Revenue | 5.25 | |||||
| EV-to-FCF | -2.17 | |||||
| Price-to-Net-Current-Asset-Value | 2.73 | |||||
| Price-to-Net-Cash | 6.79 | |||||
| Earnings Yield (Greenblatt) % | -25.18 | |||||
| FCF Yield % | -34.26 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Arctic Bioscience AS Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | 33.75 | ||
| EPS (TTM) (kr) | -1.79 | ||
| Beta | -0.49 | ||
| Volatility % | 20.13 | ||
| 14-Day RSI | 46.99 | ||
| 14-Day ATR (kr) | 0.386226 | ||
| 20-Day SMA (kr) | 10.124 | ||
| 12-1 Month Momentum % | -9.26 | ||
| 52-Week Range (kr) | 7.54 - 12 | ||
| Shares Outstanding (Mil) | 25.37 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Arctic Bioscience AS Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Arctic Bioscience AS Stock Events
| Event | Date | Price(kr) | ||
|---|---|---|---|---|
| No Event Data | ||||
Arctic Bioscience AS Frequently Asked Questions
What is Arctic Bioscience AS(OSL:ABS)'s stock price today?
The current price of OSL:ABS is kr9.85. The 52 week high of OSL:ABS is kr12.00 and 52 week low is kr7.54.
When is next earnings date of Arctic Bioscience AS(OSL:ABS)?
The next earnings date of Arctic Bioscience AS(OSL:ABS) is 2024-08-29.
Does Arctic Bioscience AS(OSL:ABS) pay dividends? If so, how much?
Arctic Bioscience AS(OSL:ABS) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers